HER2 0/1+ | HER2 2+ | HER2 3+ | p value | |
---|---|---|---|---|
Age | 0.123 | |||
≥ 65 | 186 | 65 | 81 | |
< 65 | 259 | 106 | 85 | |
Sex | 0.013 | |||
Male | 279 | 114 | 122 | |
Female | 166 | 57 | 44 | |
Tumor location | 0.953 | |||
Upper | 64 | 29 | 24 | |
Middle | 163 | 57 | 59 | |
Lower | 218 | 85 | 83 | |
Tumor size | 0.228 | |||
≥ 60 mm | 48 | 18 | 12 | |
< 60 mm | 397 | 153 | 154 | |
Tumor differentiation | < 0.001 | |||
Differentiation | 210 | 97 | 115 | |
Undifferentiation | 235 | 74 | 51 | |
Laurenerentiationtionre | < 0.001 | |||
Intestinal type | 232 | 111 | 122 | |
Diffuse type | 210 | 60 | 44 | |
Mixed type | 3 | 0 | 0 | |
T stage | 0.022 | |||
1 | 280 | 109 | 122 | |
2 | 44 | 24 | 11 | |
3 | 74 | 26 | 21 | |
4 | 47 | 12 | 12 | |
N stage | 0.877 | |||
0 | 318 | 126 | 114 | |
1 | 43 | 21 | 17 | |
2 | 34 | 8 | 18 | |
3 | 50 | 16 | 17 | |
TNM stage | 0.202 | |||
I | 288 | 122 | 114 | |
II | 83 | 27 | 29 | |
III | 74 | 22 | 23 | |
Lymphatic invasion | 0.357 | |||
Positive | 106 | 41 | 33 | |
Negative | 339 | 130 | 133 | |
Vascular invasion | 0.476 | |||
Positive | 40 | 21 | 17 | |
Negative | 405 | 150 | 149 | |
Perineural invasion | 0.077 | |||
Positive | 103 | 37 | 27 | |
Negative | 342 | 134 | 139 |